TG Therapeutics, Inc. carries a market capitalization of 5.27B, placing it among publicly traded companies globally.
| Market Cap | 5.27B |
| Enterprise Value | N/A |
TG Therapeutics, Inc.'s stock has gained approximately 30.56644% over the past 52 weeks. The 50-day moving average sits at 16.04, while the 200-day moving average is 15.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | 30.56644% |
| 50-Day Moving Average | 16.04 |
| 200-Day Moving Average | 15.15 |
| Average Volume (20 Days) | N/A |